{
  "compound": "Nabilone (Cesamet)",
  "condition": "NAUSEA_CHEMOTHERAPY",
  "effect_size": "Large (OR = 4.89)",
  "study_type": "RCT",
  "source": "NORML:CINV_RCT_005",
  "participants": "74 patients receiving cisplatin chemotherapy",
  "year": 1983,
  "notes": "Nabilone vs Prochlorperazine for CINV: Comparative Trial",
  "confidence": "medium",
  "abstract": "Nabilone significantly superior: 52% complete protection vs 18% with prochlorperazine (p<0.01)"
}